TBL1XR1 and pancreatic ductal adenocarcinoma: Patients with low TBL1XR1 expression exhibited a more prolonged overall time than those with high TBL1XR1 expression in pancreatic ductal adenocarcinoma (PDAC), and excessive expression of TBL1XR1 was linked with TNM phase (50).